Skip to main content

Potent antitumor property of Allium bakhtiaricum extracts



Allium species are magnificently nutritious and are commonly used as a part of the diet in Iran. They have health enhancing benefits including anticancer properties due to the presence of numerous bioactive compounds. Herein, we investigated in vitro and in vivo anticancer properties of Allium bakhtiaricum extracts.


Anti-growth activity of different fractions was explored in vitro on different cancerous cells using MTT assay, Annexin V/PI and SA-β-gal staining, Western blotting, flowcytometric and immunofluorescence microscopic evaluations. In vivo antitumor activity was investigated in BALB/c mice bearing 4 T1 mammary carcinoma cells.


We demonstrated that chloroformic and ethyl acetate fractions exert cytotoxic activity toward MDA-MB-231 cells, the most sensitive cell line, after 72 h of treatment with IC50 values of 0.005 and 0.006 mg/ml, respectively. Incubation of MDA-MB-231 cells with ¼ and ½ IC50-72h concentrations of each fraction resulted in a significant G2/M cell cycle arrest. ¼ IC50-72h concentration of the chloroform fraction led to the disruption of polymerization in mitotic microtubules. Exposure of human breast cancer cells to different concentrations of the extracts at different incubation times did not induce apoptosis, autophagy or senescence. Our in vivo study revealed that administration of the chloroform extract at a dose of 1 mg/kg/day strongly suppressed mammary tumor progression and decreased the number of proliferative cells in the lung tissues indicating its anti-metastatic effect.


Our findings imply that the chloroform fraction of Allium bakhtiaricum possesses the suppressive action on breast cancer through mitotic cell cycle arrest suggesting a mechanism associated with disturbing microtubule polymerization.

Peer Review reports


Cancer is considered to be a noticeable disease with worldwide distribution distinguished by uncontrolled growth and spreading the abnormal cells, which currently causes million deaths. Based on the World Health Organization (WHO) report, around 15 million new cases of cancer is estimated by 2020 [1, 2]. In particular, 60% of the world population is accounted for Asia which includes half the total burden of cancer [3]. In this regard, among Asian countries, about 50,800 new cancer cases take place in Iran, annually [4].

Cancer treatment generally consists of surgery, chemotherapy, radiotherapy, or a mixture of them, among which chemotherapy is the most effective approach to control the disease. However, chemotherapy causes adverse and inevitable side effects for the patients [5], which currently limits its application. To address this issue, using herbal medicine has gained a great attention. Plants are an invaluable source of natural products, including phytochemicals, commonly known as secondary metabolites, with diverse therapeutic applications [6,7,8]. Recently, numerous studies have shown that the use of natural products for cancer treatment results in fewer or diminished side effects as well as a longer survival period for patients [9, 10].

Importantly, folk medicine has strong historical and cultural roots in Iran, which dates back to the Old Babylonian and Assyrian periods [11, 12]. Traditional remedy has been long used in the treatment of a great number of diseases in Iran [13]. Allium is the largest and generally most important genus in the Alliaceae family and has been used as folk medicine [14, 15]. Of note, Iran is one of the valuable resources of Allium including 121 wild Allium species [16]. In folk medicine, Allium was used to treat the rheumatic and inflammatory disorders [17, 18], gout, arthritis, psoriasis, hemorrhoid, diarrhea, stomach pain [19] and gastrointestinal disorders [13, 20].

Allium species including garlic (Allium sativum) and common onion (Allium cepa) are magnificently nutritious as well [21]. In this regard, garlic or extracts obtained from garlic are being incorporated into functional foods as natural antimicrobial agents [22]. These species are cultivated and traded due to their availability across the world and their leaves and bulbs are used raw or cooked in foods [23, 24].

Accumulating evidence recognize Allium species as a rich source of secondary metabolites such as flavonoids, alkaloids, organosulfur compounds and saponins, which possess antibacterial, antiviral, antifungal, antihelmintic, antiprotozoal and anticancer properties [14, 25,26,27,28,29,30,31]. Among Allium species, Allium bakhtiaricum is native to Iran and grows on the Zagros mountains. Besides its application in traditional medicine, this plant is used to prepare a broad range of local foods. To date, Allium jesdianum, a similar species to A.bakhtiaricum has been found to have pharmacological properties including analgesic effect [32], inhibition of platelet aggregation [33] and renal stone formation [34] as well as anticancer activity [35]. To the best of our knowledge, there is no investigation of the anticancer activity of A.bakhtiaricum extracts. This motivated us to explore the in vitro and in vivo anticancer activity of different extracts obtained from A. bakhtiaricum aerial parts.


Plant material and preparation of extracts

A.bakhtiaricum was collected from Shiraz, Iran, in the spring, authenticated by Dr.Shahin Zarre and deposited at the Herbarium of Faculty of Sciences, Tehran University, Tehran, Iran (Voucher No:45496). The aerial parts were air dried prior to being grinded into powder. 50 g of dried powder was mixed with ethanol: water (80:20) at room temperature in order to obtain total extract. In addition, 100 g of plant powder was extracted sequentially by solvents with a wide range of polarities including n-hexane, chloroform, ethyl acetate and methanol using a maceration procedure. The process was repeated 3 times with the same plant material but using fresh solvents [36,37,38]. The extracts were then filtered and evaporated to dryness on a rotary evaporator under reduced pressure below 40 °C. All the extracts were stored at 4 °C until used for experiments. The yield of extraction for total extract, n-hexane, chloroform, ethyl acetate and methanol fractions were as follows: 32.57, 1.63, 1.08, 0.4 and 15.25%, respectively.

Chemicals and cell lines

MDA-MB-231 (human breast adenocarcinoma, C578), MCF-7 (human breast adenocarcinoma, C135), HT-29 (human colorectal adenocarcinoma, C466), HepG2 (liver hepatocellular carcinoma, C158), 4 T1(mouse mammary tumor, C604) and NIH3T3 (mouse embryonic fibroblasts, C156) cell lines were purchased from the cell bank of Pasture Institute of Iran (NCBI). Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) medium containing 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin (GibcoBRL, Rockville, IN, USA) at 37 °C with 5% CO2 in a humidified atmosphere inside a CO2 incubator. All solvents used were of analytical grade and purchased from Merck (Darmstadt, Germany), and the other chemicals were obtained from Sigma-Aldrich (St Louis, MO, USA).

In vitro cytotoxicity assay

The cytotoxic effects of total extract and fractions were assessed toward cancerous and non-cancerous cell lines by applying the MTT assay. Following seeding of the cells (MDA-MB-231, 3–7 × 103; MCF-7, 4–8 × 103; HT-29, 4–8 × 103; HepG2, 5–9 × 103; NIH3T3, 1 × 103) in 96-well plates for different time exposures, samples were added at concentrations ranging from 0.002 to 0.25 mg/ml to each well and then incubated for 24, 48 and 72 h. The cultivation media without extract was used as a negative control, while DMSO (dimethyl sulfoxide) (0.5%) served as the solvent control. Afterwards, cells were subjected to MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (0.5 mg/ml in phosphate buffered saline) for 4 h at 37 °C. Following the solubilization of the formed crystal formazan in DMSO, the absorbance was measured at 545 nm. The IC50 values were calculated from dose-response curves at 24, 48 and 72 h exposure times.

Flowcytometry analysis

Cell cycle phase distribution was determined by flowcytometry. Following exposure of MDA-MB-231 cells to the ¼ IC50-72h, ½ IC50-72h and IC50-72h concentrations of the chloroform and ethyl acetate fractions for 48 h, cells were collected and stained with Propidium Iodide (PI) reagent at 37 °C for 15 min in the dark. PARTEC flowcytometer (Partec GmbH, Munster, Germany) using Flowjo Software was applied for determining the DNA content [38].

Annexin-V staining assay

In order to detect apoptosis, Annexin-V/PI assay was carried out on the cells treated with ¼ IC50-72h, ½ IC50-72h and IC50-72h concentrations of the chloroform and ethyl acetate fractions at different times. Afterwards, 100 μl Annexin-V-FLUOS (Roche Applied Science, Indianapolis, IN, USA) labeling solution was added to the suspended MDA-MB-231 cells and incubated at 37 °C. The tubes were then diluted with buffer prior to being subjected to flowcytometry [39].

Western blot analysis

MDA-MB-231 cells treated with the chloroform extract at ¼ IC50-72h, ½ IC50-72h and IC50-72h concentrations for 48 h were lysed in lysis buffer (Tris 62.5 mM(pH 6.8), DTT 50 mM, SDS 10%, glycerol), and the extracted proteins were separated by 15% SDS-PAGE, electroblotted to polyvinylidene fluoride membrane (GE Health Care Life Sciences, Buckinghamshire, UK) and probed with primary antibody (LC3, 1:1000) (Cell Signaling Technology,Beverly, MA), followed by anti-rabbit IgG horseradish peroxidase (HRP) secondary antibody (1:8000) (Cell Signaling Technology, Beverly, MA). Protein bands were then detected by ECL (Enhanced chemiluminescence) advanced Western blotting detection kit (General Electric Health Care Life Sciences, Buckinghamshire, UK). Image J was used for data analysis to determine integrated density of bands. Protein concentration was measured using the Bradford assay [40].

Senescence-associated-β-galactosidase (SA-β-gal) staining

MDA-MB-231 cells were treated for 2 h with high concentrations of the ethyl acetate (0.3, 0.06 mg/ml) and chloroform(0.2, 0.05 mg/ml) fractions and then the culture media were renewed. Besides, MDA-MB-231 cells were also treated with 0.002 and 0.001 mg/ml of the chloroform as well as 0.003 and 0.001 mg/ml of the ethyl acetate fractions. After washing the cells in PBS and fixing them with 2% formaldehyde, cells were incubated at 37 °C (no CO2) with fresh senescence associated β-Gal (SA-β-Gal) (Abcam, Cambridge, MA) stain solution [41]. Stained cells were visualized maximal in 12–16 h. β-galactosidase activity was tracked under a Nikon eclipse TS100 inverted microscope for incidence of senescence.

Immunofluorescence microscopy of α-tubulin

MDA-MB-231 cells were seeded on 8-well glass slides(SPL Life Sciences, Korea) and treated with ¼ IC50-72h concentration of the chloroform extract for 48 h. Having washed with phosphate-buffered saline, cells were fixed in glutaraldehyde (1% in PBS) at room temperature for 10 min. Afterwards, the fixed cells were washed again by PBS and permeabilized using washing buffer (0.1% Triton X-100, 1% bovine serum albumin in TBS) for 10 min. Cells were then incubated for 30 min with mouse anti-α-tubulin monoclonal antibody (1:100) (Sigma-Aldrich, USA) at room temperature followed by incubation with FITC conjugated anti-mouse IgG antibody (1:500) (Bioscience, CA) for 30 min. The nuclei were stained with propidium iodide (10 mg/ml) (Sigma–Aldrich, USA) [42, 43]. Microtubule networks were detected under a Nikon H600L fluorescence microscope.

In vivo study

Female BALB/c mice (6–8 week old) were purchased from the National Animal Center (Pasteur Institute of Karaj) and maintained under standard conditions of 12/12-h light–dark cycle, with food and water provided ad libitum. Treatment of animals was performed in accordance with the guidelines approved by the animal ethics committee of Pasteur Institute of Iran. Mice were inoculated with 106cells/50 μl of exponentially 4 T1 cells into the mammary fat pad. Following daily observation, once the tumor masses were developed, mice bearing tumor were randomly distributed into eight groups (n = 8). To detect the tumor suppressive role of the chloroformic and ethyl acetate fractions, mice were daily administered by intra-peritoneal injection of vehicle alone (DMSO) and three doses of the chloroformic and ethyl acetate fractions (1, 10 and 20 mg/kg) 5 days a week for 28 days. Mice received no treatment in the negative control group. During the experiments, the tumor growth was tracked every other day and the tumor volume was determined in two dimensions thrice a week using a digital caliper. The tumor volume (mm3) was calculated according to the formula: (length × width2)/2. Treated mice were daily monitored for toxicity including weight loss, discomfort and death. Following anesthesia with 60 mg/kg of sodium pentobarbital, the mouse chest was surgically opened and concurrently perfused by 0.9% saline and then tissue samples including the tumor and lungs were dissected from the animals. Samples were weighed, measured and then placed in 10% formalin for fixation and histopathological analysis.

Histopathology of the tumors

The fixed tissues were embedded into paraffin blocks, and 5 μm sections were prepared. The tissue sections were picked up onto a glass slide and deparaffinized, rehydrated, and subjected to Hematoxylin and Eosin (H&E) (Merck, Darmstadt, Germany) staining. A Carl Zeiss AxioImager microscope and Image M1 Software (Carl Zeiss, Jena, Germany) were used to provide images of randomly chosen fields at 400x magnification.

Statistical analysis

The data are expressed as mean ± SEM of at least triplicate determinations. Differences between the groups were evaluated by using one-way analysis of variance (ANOVA) followed by posthoc Tukey multiple comparison test using Graph Pad Prism 6 software. P value less than 0.05 was considered as significant.


Cytotoxic activity of Allium bakhtiaricum extracts

IC50 values of total extract and different fractions of A.bakhtiaricum upon 24, 48 and 72 h of treatment toward all the tested cell lines are presented in Table 1. All the extracts caused loss of cell viability in a concentration and time dependent manner on the cell lines. Among different incubation times, a strong cytotoxic activity was revealed following 72 h of incubation of the cancerous cell lines with A.bakhtiaricum extracts. As shown in Table 1, the lowest IC50 values for the extracts were recorded as follows: total < chloroform ≤ ethyl acetate fractions at 72 h. Remarkably, of all the cell lines, MDA-MB-231 cell line was the most sensitive to the chloroformic and ethyl acetate fractions with IC50 values of 0.005 and 0.006 mg/ml, respectively.

Table 1 IC50 values (mg/ml) for cytotoxic activity of different extracts towards MDA-MB-231, HT-29, HepG2 and MCF-7 cells a

In order to explore cell viability of the most effective fractions in a normal cell line, the MTT assay was also performed on NIH3T3 (mouse embryo fibroblast) after 72 h of treatment. Our results indicated that the IC50 values of the chloroformic and ethyl acetate fractions (0.05 and 0.08 mg/ml) were higher against NIH3T3 cells than those obtained from these fractions on cancer cell lines.

Cell cycle arrest induced by the chloroformic and ethyl acetate fractions in MDA-MB-231 cells

Since progression of the cells through the various phases of the cell cycle results in cell proliferation [44], we next evaluated the effects of both chloroform and ethyl acetate fractions, as the most cytotoxic extracts, on cell cycle distribution of MDA-MB-231 cell line using flowcytometry. To do this, cultured MDA-MB-231 cells were exposed to the IC50-72h, ½ IC50-72h and ¼IC50-72h concentrations of the chloroform and ethyl acetate fractions for 48 h, stained with PI and analyzed by flowcytometry. Our findings revealed that MDA-MB-231cells treated with ¼ and ½IC50-72h concentrations of the chloroformic and ethyl acetate fractions caused a statistically significant rise in the percentage of cell population in G2 phase after 48 h (Table 2). Thus, it appears that these fractions are able to cause cell cytotoxicity by modulating the cell cycle profile and inducing G2/M phase arrest.

Table 2 Effect of chloroform and ethyl acetate fractions at different concentrations on MDA-MB-231 cell cycle progressiona

Apoptosis evaluation by Annexin-V/PI staining

To ascertain whether cytotoxic effect of the chloroform or ethyl acetate fraction was due to apoptosis induction, MDA-MB-231 cells were labeled using annexinV/PI and analyzed by flowcytometry. Following treatment with IC50-72h, ½ and ¼ IC50-72h concentrations of chloroformic and ethyl acetate fractions, the percentage of viable cells were significantly declined after 72, 48, 24 and 12 h of incubation; however no significant increase was observed in the number of apoptotic cells. Of note, an upward trend was observed in the population of necrotic cells with increasing concentration of the fractions from ¼ IC50-72h to IC50-72h values. Also, apoptotic change was not detected after 6 h of exposure of the cells to the fractions (Additional file 1). As a whole, our results implied that ethyl acetate and chloroform extracts possess a non-apoptotic anti-cancer activity.

Monitoring autophagy after treatment of MDA-MB-231 cells with the fractions

To determine whether cell death was resulted from autophagy activation, LC3-II accumulation in MDA-MB-231 cells, treated for 48 h with different concentrations of the chloroformic extract, was assessed by Western blotting. A hallmark of autophagy activation is the change of the cytosolic form of LC3 (LC3-I) to its lipidized form (LC3-II) [45]. Hence, we compared the LC3 expression in the chloroformic fraction-treated and untreated MDA-MB-231 cells. As our findings show, upon treatment of MDA-MB-231 cells with the chloroformic fraction, no significant change is observed in the LC3-II expression (Fig. 1.). Regarding Western blotting, the incidence of controlled autophagy in the untreated cell was shown by the presence of LC3-II.

Fig. 1

Western blot analysis of LC3-II expression in MDA-MB-231 cells treated with the chloroform extract at 0.005, 0.0025 and 0.0012 mg/ml for 48 h. GAPDH was used as a loading control. Protein band intensities were quantified by Image J. Data are the mean ± SE of three separate experiments

Senescence investigation in the chloroformic and ethyl acetate extracts-treated MDA-MB-231 cells

It has been proposed that plant derived compounds may exert their anticancer activity via senescence mechanism due to the presence of alkaloids [46]. In addition, cell growth arrest is likely through the senescence induction [47]. Considering our findings, which indicated a cell cycle arrest following the treatment with the extracts and knowing that Allium possess a wide variety of natural compounds such as alkaloids [48, 49], we sought to explore whether a low dose and chronic treatment of the chloroform and ethyl acetate fractions could prevent the growth of breast cancer cells by inducing the premature senescence. Finding β-galactosidase positive cells implies an increased lysosomal mass and it is commonly considered as a well-established senescence marker [41]. We noticed that MDA-MB-231 cells treated with the chloroformic and ethyl acetate fractions showed no detectable SA-β-gal activity as illustrated in Fig. 2a, b. In contrast, the SA-β-gal positive cells, treated with 1 μM of Adriamycin, exhibited a blue color with a flattened and enlarged morphology, which are indicatives of senescence features (Fig. 2c) [50].

Fig. 2

Acute and chronic treatment with the chloroformic and ethyl acetate fractions did not induce cell senescence. MDA-MB231 cells were treated with (a) high concentrations of chloroformic (0.2, 0.05 mg/ml) and ethyl acetate (0.3, 0.06 mg/ml) fractions and (b) low concentrations of chloroformic (0.001, 0.002 mg/ml) and ethyl acetate (0.001, 0.003 mg/ml) fractions for 10 days and analyzed for the senescence-associated β-galactosidase activity. (c) Arrows show blue cells with a typical senescent flattened and enlarged morphology in MCF-7 cells treated with 1 μM adriamycin as a positive control and (d) untreated MDA-MB231 cells were considered as a negative control. The image shown is representative of at least three independent experiments

Disarrangement of microtubules induced by the chloroform fraction

Because microtubule network perturbation can account for the subsequent mitotic arrest [43], herein, we examined whether the chloroform fraction treatment affected the cellular microtubule network. To do this, MDA-MB-231 cells were treated with 4 μM paclitaxel and ¼ IC50-72h concentration of the chloroform extract, separately. Following 48 h of incubation, the microtubule network was observed by immunocytochemistry (Fig. 3). A normal arrangement and organization of microtubule network was visualized in the control cells (Fig. 3a), whereas paclitaxel enhanced microtubule density and caused long thick microtubule bundles to appear around the nucleus (Fig. 3b). Treating cells with the chloroformic fraction resulted in similar changes as those of paclitaxel-treated cells, demonstrating microtubule network as a possible intracellular target for components of the chloroform fraction. In order to quantify these findings, we calculated the percentage of cells bearing microtubule disarrangement and compared it to the paclitaxel-treated cells. The results were as follows: 96.95 ± 3.04% for paclitaxel- and 83.33 ± 4.16% for the chloroformic fraction-treated cells. Our outputs indicated a significant change in the microtubule network of the cells treated with the chloroformic extract.

Fig. 3

Effect of the chloroformic extract on the organization of cellular microtubule network. The microtubule network (green) and the Nuclei (red) are shown in (a) MDA-MB-231 cells; MDA-MB-231 cells were treated with (b) 4 μM of paclitaxel, and (c) ¼ IC50-72hof the chloroform extract after a 48 h incubation. The cellular microtubules were observed by Nikon H600L fluorescence microscope (original magnification 400x)

Chloroformic and ethyl acetate fractions suppressed primary tumor growth

To verify the antitumor activity of the chloroform and ethyl acetate fractions in vivo, BALB/c mice were subcutaneously (s.c.) injected with 4 T1 murine tumor cells. Following tumor development on day 7, the mice were distributed in 8 groups and treated with either the vehicle or the chloroformic and ethyl acetate fractions (1, 10, 20 mg/kg/day) for 21 days. As illustrated in Fig. 4a.,i.p. administration of 1 mg/kg/day of the chloroform extract led to a significant tumor growth suppression from the second week (p < 0.01) to the last week (p < 0.0001) of the treatment compared to the vehicle-control group. However, tumor volume reduction was observed after 4 weeks of treatment with 10 and 20 mg/kg/day of the chloroform extract. On the other hand, i.p. administration of 1 mg/kg/day of the ethyl acetate fraction was unable to significantly inhibit tumor growth within the 3 weeks of injection, and a remarkable potency was only observed following 4 weeks of treatment (Fig. 4b). With an increase in the dose of ethyl acetate fraction from 1 to 20 mg/kg/day, tumor growth began to regress significantly compared to the control animals from week 2 to 4 of the treatment. The maximum effect in terms of tumor size was seen for the chloroform fraction following 4 weeks of treatment at 1 mg/kg/day. Consistent with these data, tumor weight was also different among the control and the treated groups. The tumor weight was reduced from 2.02 ± 0.27 g in the control group to 1.01 ± 0.34 g and 0.98 ± 0.11 g in the chloroform and ethyl acetate treated groups, respectively. Also, according to Fig. 4c, the size of the tumor in the control group was larger than that of the treated mice. Remarkably, no weight loss was detected either in the control-vehicle or the treated groups after 28 days.

Fig. 4

Different doses (1, 10, 20 mg/kg) of (a) chloroform and (b) ethyl acetate fractions affected primary tumor growth after 4 weeks of daily treatment. (c) Images of tumors harvested from control and the treated mice (1 mg/kg). Data are expressed as mean ± SEM, n = 8 mice per group

Effect of the chloroform and ethyl acetate fractions on the mammary tumor tissues and metastasis to the lung

In the mice bearing 4 T1, the tumor tissues displayed malignant cells with the features including loss of polarity and a number of typical mitotic figures (Fig. 5a). These types of cells were nominated as an invasive lineage representing a suitable model to evaluate the potency of anticancer drugs due to its similarities with metastatic human breast cancer [51]. In the groups treated with 1 mg/kg/day of the chloroform or ethyl acetate fractions, a number of tumor cells in the process of necrosis were observed (Fig. 5b, c); however, tumors dissected from mice treated with the chloroform fraction presented a reduced number of proliferative cells than those from the ethyl acetate fraction at the same dose. These findings are in line with our tumor volume determinations, further corroborating a greater efficiency for the chloroformic fraction in suppressing tumor growth.

Fig. 5

Effect of the chloroformic and ethyl acetate fractions at 1 mg/kg/day on solid tumors in Balb/c mice injected with 4 T1 cells. The mice were killed 32 days after cell injection. (a-c) tumor and (d-f) lung sections following H&E staining (original magnification 400x and 100x)

The findings of histopathology also exhibited less foci of metastasis in the lungs of the animals treated with chloroform and ethyl acetate fractions compared to the vehicle-treated animals, indicating an anti-invasive property of the fractions (Fig. 5d-f). Besides, a difference was observed between the metastatic lung foci of the chloroform and ethyl acetate treated groups, with the chloroform treated lung tissues harboring less nodules than those of the ethyl acetate-treated group.


Natural phytochemicals are well-known for having beneficial impacts in treatment of a broad range of illnesses. Total extracts obtained from medicinal plants contain a number of ingredients with more effective therapeutic properties and fewer side effects than a single natural compound alone [52]. It is noteworthy to mention that an extract may contain a wide variety of compounds affecting different pathways involved in cell death [53], a property that may be advantageous in treating diseases involving multiple mechanisms such as cancer [54]. Allium vegetables have been traditionally used for centuries in Asian, American and European medicine to alleviate diseases [55], but recently, a number of studies have been carried out on anti-cancer activity of Allium species [14, 25, 26, 56]. Allium species have numerous uses in folk medicine in Iran [34], however no studies have been reported on the anticancer activity of Allium bakhtiaricum. In the present study, we focused on evaluating the influence of A.bakhtiaricum extracts on the proliferation of different cancer cells along with their possible underlying mechanisms. In addition, we further verified the antitumor effect of the most potent extract in an in vivo model.

The current study revealed for the first time that A.bakhtiaricum extract is capable of inhibiting the growth of breast cancer cells. In this regard, A.bakhtiaricum total extract and different fractions significantly diminished cell viability in a concentration- and time-dependent manner. According to the obtained IC50 values, efficacy of the extracts were in the order of total > chloroform > ethyl acetate > methanol extracts at three different times (24, 48 and 72 h). Notably, among the different tested cell lines, MDA-MB-231 cells were the most sensitive in response to all the extracts. Our findings also revealed that the chloroformic and ethyl acetate fractions had minimal cytotoxic effect on normal cells with IC50 values of 0.05 and 0.08 mg/ml, respectively, indicating a selective inhibitory impact on cancer cells with no effect on normal cells. Hence, these two fractions could be considered as potential chemotherapeutics in cancer therapy.

In order to detect the type of cell death operating in cells treated with chloroform and ethyl acetate treatments as the most effective extracts, different cell death mechanisms were investigated. Our AnnexinV/PI test displayed a minimal cell apoptosis in the late stage upon exposure of MDA-MB-231 cells to ½IC50-72h concentration of the chloroform extract after 24 h. On the other hand, a large percentage of cells appeared in the necrotic stage at 24 h and even at less upon exposure of breast cancer cells to both fractions at ½IC50-72h and ¼ IC50-72h concentrations. Despite being incapable of inducing major apoptosis in cancer cells, the two fractions, however, caused cell death through induction of cell cycle arrest at G2/M phase at ¼ and ½ IC50-72h concentrations in MDA-MB-231 cells after 48 h of treatment. These observations suggest a preventive effect for the extracts against cancerous cells entering into mitosis phase, a property associated with the mechanism of the action of most anticancer drugs [57]. We next were interested in whether senescence can be a causative trigger for cell cycle arrest, thus, we examined the treated cells by SA-β-gal staining. Our results showed that long-term incubation with low concentrations (0.001 and 0.002 mg/ml) of the chloroformic as well as ethyl acetate (0.001 and 0.003 mg/ml) fractions induced no senescence-like cell growth arrest. Similarly, no sign of senescence was detected following acute treatment of MDA-MB-231 cells with the chloroformic fraction at 0.2 and 0.05 mg/ml along with the ethyl acetate extract at 0.3 and 0.06 mg/ml.

On the other hand, multiple lines of evidence indicate that suppression of apoptosis can result in autophagy activation [58]. This assumption encouraged us to evaluate autophagy in MDA-MB-231 cells treated with the extracts. As demonstrated by our results, the chloroformic fraction did not affect the expression level of LC3-II, the autophagic marker, at concentrations in which cell cycle arrest occurred at 48 h. These results are consistent with our findings on senescence, supporting the notion that cellular senescence and autophagy are closely linked events [40]. Therefore, we observed neither senescence nor autophagy upon treatment of breast cancer cells with the extracts. To fully elucidate the operating mechanism(s) of cell death would, therefore, require further investigations.

An interesting result in the current study was the similarity between the effects of the chloroformic fraction on tubulin polymerization at ¼ IC50-72h concentration to that of paclitaxel, where thick bundles of microtubules appeared around the nucleus. These findings suggest alteration in microtubule dynamics as a probable mechanism through which the chloroform fraction may act, leading to cell cycle arrest within G2/M, a role associated with naturally occurring antimitotic agents [59]. It will be of interest to design further experiments to ascertain this hypothesis.

In order to verify the anticancer potential of the two extracts, a syngenic mice model using 4T1 cell line was selected due to its high reproducibility and suitability for testing the efficiency of chemotherapeutic agents used for treating breast cancer, particularly metastatic breast cancer [60]. We found that the daily administration of the chloroformic and ethyl acetate fractions were able to suppress tumor growth in the murine tumor models at 1, 10 and 20 mg/kg based on the regression of tumor volumes following 4 weeks of treatment, which are in line with the in vitro results. Importantly, the chloroform fraction showed more efficiency in tumor volume reduction at different doses within 4 weeks of treatment compared to the ethyl acetate fraction. Moreover, our findings corroborate that 1 mg/kg of both extracts is the minimum effective dose to reduce tumor volume. Furthermore, after a significant drop in tumor volume upon treatment with both fractions in the first week, the tumor size remained constant within the following 3 weeks, demonstrating a rapid onset of action with a good penetration into the tumor. These results may be related to the presence of natural compounds including organosulfurs, saponins, terpenoids, alkaloids and flavonoids in the extracts of Allium species, which make them suitable candidates in fighting cancer [5, 14, 15, 53]. Notably, the anticancer property speculated for most allium species due to the presence of flavonoids, is through promoting apoptosis [61], thus, we assume that the non-apoptotic cell death occurred in the current study is most likely associated with the presence of other natural bioactives.

Consistently, H&E staining of the tumors also revealed a reduction in the number of actively dividing cells, a hallmark of cancer cells, following the injection of the two fractions at 1 mg/kg/day, compared to the control-vehicle; however, more cells in the process of necrosis were observed in the group administered with the chloroform fraction than with the ethyl acetate group. In addition, the survival rates of mice were indicative of a good tolerance towards the treatments, reinforcing the idea that the total death occurred as a result of the tumor rather than the toxicity of the extracts. The inhibitory effect of both fractions on the spreading of the 4 T1 breast cancer cells to a secondary site, i.e., lung, was also diminished in the treated groups, as recognized by a reduction in the number of metastatic nodules. In agreement with our previous data, the development of lung metastasis was lower in the chloroform-treated mice bearing 4 T1 cells than in the ethyl acetate-treated group.


For the first time, the findings of the current study demonstrated that the chloroform extract of A.bakhtiaricum potently suppressed the tumor growth in vitro and in vivo, a property which may be attributed to the presence of bioactive compounds in this plant with anti-breast cancer potential. Experiments to further identify these active ingredients as well as the mechanisms of their anticancer activity are presently ongoing in our laboratory.



Allium bakhtiaricum


Allium cepa


Allium sativum


Dulbecco’s Modified Eagle’s Medium


Dimethyl Sulfoxide


Enhanced Chemiluminescence


Fetal Bovine Serum


3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide


Senescence Associated β-galactosidase


  1. 1.

    Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–93.

    Article  Google Scholar 

  2. 2.

    McGuire S. World cancer report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO press, 2015. Adv Nutr (Bethesda Md.). 2016;7:418–419.

    Article  Google Scholar 

  3. 3.

    Sankaranarayanan R, Ramadas K, Y-l Q. Managing the changing burden of cancer in Asia. BMC Med. 2014;12:3–20.

    Article  Google Scholar 

  4. 4.

    Alireza S, Mehdi N, Ali M, Alireza M, Reza M, Parkin D. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev. 2005;6:359.

    Google Scholar 

  5. 5.

    Yu Z, Zhang T, Zhou F, Xiao X, Ding X, He H, Rang J, Quan M, Wang T, Zuo M. Anticancer activity of saponins from Allium chinense against the B16 melanoma and 4T1 breast carcinoma cell. Evid Based Complement Alternat Med. 2015;2015:725023.

    Google Scholar 

  6. 6.

    Scheck AC, Perry K, Hank NC, Clark WD. Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells. BMC Complement Altern Med. 2006;6:27–35.

    Article  Google Scholar 

  7. 7.

    Ramasamy TS, Yu JS, Selden C, Hodgson H, Cui W. Application of three-dimensional culture conditions to human embryonic stem cell-derived definitive endoderm cells enhances hepatocyte differentiation and functionality. Tissue Eng A. 2012;19:360–7.

    Article  Google Scholar 

  8. 8.

    Maqsood M, Qureshi R, Ikram M, Ahmad MS, Jabeen B, Asi MR, Khan JA, Ali S, Lilge L. In vitro anticancer activities of Withania coagulans against HeLa, MCF-7, RD, RG2, and INS-1 cancer cells and phytochemical analysis. Integrative Med Res. 2018;7:184–91.

    Article  Google Scholar 

  9. 9.

    Rayan A, Raiyn J, Falah M. Nature is the best source of anticancer drugs: indexing natural products for their anticancer bioactivity. PLoS One. 2017;12:e0187925.

    Article  Google Scholar 

  10. 10.

    Seca A, Pinto D. Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. Int J Mol Sci. 2018;19:263.

    Article  Google Scholar 

  11. 11.

    H-a M, Sajjadi S-E, Noroozi M, Mirhoseini M. Collection and assessment of traditional medicinal plants used by the indigenous people of Dastena in Iran. J HerbMed Pharmacol. 2016;5:54–60.

  12. 12.

    Amiri MS, Joharchi MR. Ethnobotanical investigation of traditional medicinal plants commercialized in the markets of Mashhad. Iran Avicenna J Phytomed. 2013;3:254.

    PubMed  Google Scholar 

  13. 13.

    Asadi-Samani M, Kafash-Farkhad N, Azimi N, Fasihi A, Alinia-Ahandani E, Rafieian-Kopaei M. Medicinal plants with hepatoprotective activity in Iranian folk medicine. Asian Pac J Trop Biomed. 2015;5:146–57.

    CAS  Article  Google Scholar 

  14. 14.

    Sengupta A, Ghosh S, Bhattacharjee S. Allium vegetables in cancer prevention: an overview. Asian Pac J Cancer Prev. 2004;5:237–45.

    PubMed  Google Scholar 

  15. 15.

    Corea G, Fattorusso E, Lanzotti V. Saponins and flavonoids of Allium t riquetrum. J Nat Prod. 2003;66:1405–11.

    CAS  Article  Google Scholar 

  16. 16.

    Aryakia E, Karimi HR, Naghavi MR, Fazeli SAS. Morphological characterization of intra-and interspecific diversity in some Iranian wild Allium species. Euphytica. 2016;211:185–200.

    CAS  Article  Google Scholar 

  17. 17.

    Jayanthi M, Dhar M, Jayanthi M. Anti-inflammatory effects of Allium sativum (garlic) in experimental rats. Biomedicine. 2011;31:84-89.

  18. 18.

    Kim J-E, Park K-M, Lee S-Y, Seo J-H, Yoon I-S, Bae C-S, Yoo J-C, Bang M-A, Cho S-S, Park D-H. Anti-inflammatory effect of Allium hookeri on carrageenan-induced air pouch mouse model. PLoS One. 2017;12:e0190305.

    Article  Google Scholar 

  19. 19.

    Moradi Y, Moradi-Sardareh H, Ghasemi H, Mohamadi N, Moradi M-N, Hosseini-Zijoud S-M. Medicinal properties of Persian shallot. Eur J Exp Biol. 2013;3:371–9.

    Google Scholar 

  20. 20.

    Vítor JM, Vale FF. Alternative therapies for helicobacter pylori: probiotics and phytomedicine. FEMS Immunol Med Microbiol. 2011;63:153–64.

    Article  Google Scholar 

  21. 21.

    Štajner D, Igić R, Popović B, Malenčić D. Comparative study of antioxidant properties of wild growing and cultivated Allium species. Phytother Res. 2008;22:113–7.

    Article  Google Scholar 

  22. 22.

    Hedges L, Lister C. The nutritional attributes of Allium species. Crop and food research confidential report; 2007.

    Google Scholar 

  23. 23.

    Teshika JD, Zakariyyah AM, Toorabally Z, Zengin G, Rengasamy KR, Pandian SK, Mahomoodally FM. Traditional and modern uses of onion bulb (Allium cepa L.): a systematic review. Crit Rev Food Sci Nutr. 2018;58:1–75.

    Article  Google Scholar 

  24. 24.

    Brewster JL. Onions and other vegetable alliums, vol. 15, second edn. Wellesbourne. UK: CABI; 2008.

    Google Scholar 

  25. 25.

    Bianchini F, Vainio H. Allium vegetables and organosulfur compounds: do they help prevent cancer? Environ Health Perspect. 2001;109:893.

    CAS  Article  Google Scholar 

  26. 26.

    Ferrucci V, Boffa I, De Masi G, Zollo M. Natural compounds for pediatric cancer treatment. Naunyn Schmiedeberg's Arch Pharmacol. 2016;389:131–49.

    CAS  Article  Google Scholar 

  27. 27.

    Thomson M, Ali M. Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent. Curr Cancer Drug Targets. 2003;3:67–81.

    CAS  Article  Google Scholar 

  28. 28.

    Wu H, Dushenkov S, Ho C-T, Sang S. Novel acetylated flavonoid glycosides from the leaves of Allium ursinum. Food Chem. 2009;115:592–5.

    CAS  Article  Google Scholar 

  29. 29.

    M Calderon-Montano J, Burgos-Morón E, Pérez-Guerrero C, López-Lázaro M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem. 2011;11:298–344.

    Article  Google Scholar 

  30. 30.

    Mohammadi-Motlagh H-R, Mostafaie A, Mansouri K. Anticancer and anti-inflammatory activities of shallot (Allium ascalonicum) extract. Arch Med Sci. 2011;7:38.

    Article  Google Scholar 

  31. 31.

    Azadi HG, Ghaffari SM, Riazi GH, Ahmadian S, Vahedi F. Antiproliferative activity of chloroformic extract of Persian shallot, Allium hirtifolium, on tumor cell lines. Cytotechnology. 2008;56:179–85.

    Article  Google Scholar 

  32. 32.

    Zarabi S, Ahmadi S, Rostami R. Anticancer activity evaluation of methanolic extract of Allium Jesdianum and Nectaroscordeum Coelzi against HeLa and K562 cell lines. Yafte. 2017;19:31-41

  33. 33.

    Lorigooini Z, Ayatollahi SA, Amidi S, Kobarfard F. Evaluation of anti-platelet aggregation effect of some Allium species. Iran J Pharm Res. 2015;14:1225.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Vahdani R, Mehrabi S, Malekzadeh J, Jannesar R, Sadeghi H, Shafaeifar A. Effect of hydrophilic extract of Allium jesdianum on ethylene glycol-induced renal stone in male wistar rats. Armaghane Danesh Bimonthly J. 2012;16:566–77.

    Google Scholar 

  35. 35.

    Mimaki Y, Kuroda M, Fukasawa T, Sashida Y. Steroidal glycosides from the bulbs of Allium jesdianum. J Nat Prod. 1999;62:194–7.

    CAS  Article  Google Scholar 

  36. 36.

    Abou-Elella FM, Ali RFM. Antioxidant and anticancer activities of different constituents extracted from Egyptian prickly pear Cactus (Opuntia Ficus-Indica) Peel. Biochem Anal Biochem. 2014;3:2161–1009.1000158.

    Article  Google Scholar 

  37. 37.

    Nair MS, Soren K, Singh V, Boro B. Anticancer activity of fruit and leaf extracts of Averrhoa bilimbi on mcf-7 human breast cancer cell lines: a preliminary study. Austin J Pharmacol Ther. 2016;4:1–5.

    Google Scholar 

  38. 38.

    Farmani F, Moein M, Amanzadeh A, Kandelous HM, Ehsanpour Z, Salimi M. Antiproliferative evaluation and apoptosis induction in MCF-7 cells by Ziziphus spina christi leaf extracts. Asian Pac J Cancer Prev. 2016;17:315–21.

    Article  Google Scholar 

  39. 39.

    Salimi M, Ardestaniyan M, Mostafapour Kandelous H, Saeidnia S, Gohari A, Amanzadeh A, Sanati H, Sepahdar Z, Ghorbani S, Salimi M. Anti-proliferative and apoptotic activities of constituents of chloroform extract of Juglans regia leaves. Cell Prolif. 2014;47:172–9.

    CAS  Article  Google Scholar 

  40. 40.

    El Hasasna H, Athamneh K, Al Samri H, Karuvantevida N, Al Dhaheri Y, Hisaindee S, Ramadan G, Al Tamimi N, AbuQamar S, Eid A. Rhus coriaria induces senescence and autophagic cell death in breast cancer cells through a mechanism involving p38 and ERK1/2 activation. Sci Rep. 2015;5:13013.

    Article  Google Scholar 

  41. 41.

    Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci. 1995;92:9363–7.

    CAS  Article  Google Scholar 

  42. 42.

    Jackson SJ, Singletary KW. Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J Nutr. 2004;134:2229–36.

    CAS  Article  Google Scholar 

  43. 43.

    Ling Y-H, Jiang J-D, Holland JF, Perez-Soler R. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol. 2002;62:529–38.

    CAS  Article  Google Scholar 

  44. 44.

    Schafer K. The cell cycle: a review. Vet Pathol. 1998;35:461–78.

    CAS  Article  Google Scholar 

  45. 45.

    Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140:313–26.

    CAS  Article  Google Scholar 

  46. 46.

    Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R, Darwiche N. Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis. Apoptosis. 2015;20:1531–62.

    CAS  Article  Google Scholar 

  47. 47.

    Heiss EH, Schilder YD, Dirsch VM. Chronic treatment with resveratrol induces redox stress-and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells. J Biol Chem. 2007;282:26759–66.

    CAS  Article  Google Scholar 

  48. 48.

    Shenoy C, Patil M, Kumar R, Patil S. Preliminary phytochemical investigation and wound healing activity of Allium cepa Linn (Liliaceae). Int J Pharm Pharm Sci. 2009;2:167–75.

    Google Scholar 

  49. 49.

    Guohua H, Yanhua L, Rengang M, Dongzhi W, Zhengzhi M, Hua Z. Aphrodisiac properties of Allium tuberosum seeds extract. J Ethnopharmacol. 2009;122:579–82.

    Article  Google Scholar 

  50. 50.

    Elmore LW, Rehder CW, Di X, McChesney PA, Jackson-Cook CK, Gewirtz DA, Holt SE. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem. 2002;277:35509–15.

    CAS  Article  Google Scholar 

  51. 51.

    Mousavi E, Tavakolfar S, Almasirad A, Kooshafar Z, Dehghani S, Afsharinasab A, Amanzadeh A, Shafiee S, Salimi M. In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells. Cancer Chemother Pharmacol. 2017;79:1195–203.

    CAS  Article  Google Scholar 

  52. 52.

    Hsieh YJ, Huang HS, Leu YL, Peng KC, Chang CJ, Chang MY. Anticancer activity of Kalanchoe tubiflora extract against human lung cancer cells in vitro and in vivo. Environ Toxicol. 2016;31:1663–73.

    CAS  Article  Google Scholar 

  53. 53.

    Khazaei S, Esa NM, Ramachandran V, Hamid RA, Pandurangan AK, Etemad A, Ismail P. In vitro antiproliferative and apoptosis inducing effect of Allium atroviolaceum bulb extract on breast, cervical, and liver cancer cells. Front Pharmacol. 2017;8:5.

    Article  Google Scholar 

  54. 54.

    Pecorino L. Molecular biology of cancer: mechanisms, targets, and therapeutics. Italy: Oxford university press; 2012.

  55. 55.

    Park HS, Choi EJ, Lee J-H, Kim G-H. Evaluation of Allium vegetables for anti-Adipogenic, anti-Cancer, and anti-inflammatory activities InVitro. J Life Sci. 2013;5:127–32.

    Article  Google Scholar 

  56. 56.

    Timité G, Mitaine-Offer A-C, Miyamoto T, Tanaka C, Mirjolet J-F, Duchamp O, Lacaille-Dubois M-A. Structure and cytotoxicity of steroidal glycosides from Allium schoenoprasum. Phytochemistry. 2013;88:61–6.

    Article  Google Scholar 

  57. 57.

    Shang L-H, Li C-M, Yang Z-Y, Che D-H, Cao J-Y, Yu Y. Luffa echinata Roxb. Induces human colon cancer cell (HT-29) death by triggering the mitochondrial apoptosis pathway. Molecules. 2012;17:5780–94.

    CAS  Article  Google Scholar 

  58. 58.

    Eisenberg-Lerner A, Bialik S, Simon H-U, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009;16:966–75.

    CAS  Article  Google Scholar 

  59. 59.

    Jordan M. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anti Cancer Agents. 2002;2:1–17.

    CAS  Article  Google Scholar 

  60. 60.

    McCarthy M, Auda G, Agrawal S, Taylor A, Backstrom Z, Mondal D, Moroz K, Dash S. In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer. Exp Mol Pathol. 2014;97:6–15.

    CAS  Article  Google Scholar 

  61. 61.

    Zeng Y, Li Y, Yang J, Pu X, Du J, Yang X, Yang T, Yang S. Therapeutic role of functional components in alliums for preventive chronic disease in human being. Evid Based Complement Alternat Med. 2017;2017:9402849.

    Article  Google Scholar 

Download references


Authors are thankful to the Department of Physiology and Pharmacology, Pasteur Institute of Iran for providing research facilities to prepare this valuable document.


Authors are grateful to the Iran National Science Foundation grant No 9480939 for providing the materials for this study.

Availability of data and materials

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

Author information




KV performed all experiments and wrote the manuscript. SD and RT helped in animal and in vitro experiments. FSA contributed in data acquisition and analysis. SI and MS designed and supervised the study plan, helped in data analysis and manuscript writing. All authors have read and approved the manuscript before submission.

Corresponding authors

Correspondence to Saeed Irian or Mona Salimi.

Ethics declarations

Ethics approval

All animals used in the study were handled in accordance with the guidelines approved by the animal ethics committee of Pasteur Institute of Iran.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional files

Additional file 1:

Table S1. Percentage of MDA-MB-231 cells in each state after treatment with the fractions at 72 h. Table S2. Percentage of MDA-MB-231 cells in each state after treatment with the fractions at 48 h. Table S3. Percentage of MDA-MB-231 cells in each state after treatment with the fractions at 24 h. Table S4. Percentage of MDA-MB-231 cells in each state after treatment with the fractions at 12 h. Table S5. Percentage of MDA-MB-231 cells in each state after treatment with the fractions at 6 h. (DOCX 28 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Vafaee, K., Dehghani, S., Tahmasvand, R. et al. Potent antitumor property of Allium bakhtiaricum extracts. BMC Complement Altern Med 19, 116 (2019).

Download citation


  • Allium bakhtiaricum
  • Breast cancer
  • Fraction
  • Balb/c mice
  • Cell cycle